Provided by Tiger Fintech (Singapore) Pte. Ltd.

Arrowhead Pharmaceuticals

14.42
+0.38002.71%
Post-market: 14.420.00000.00%18:39 EDT
Volume:1.40M
Turnover:20.42M
Market Cap:1.98B
PE:-2.80
High:14.97
Open:14.23
Low:14.22
Close:14.04
Loading ...
Jan 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 05, 2024

Major Issues Report

Form 8-K - Current report
Jan 04, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 04, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 04, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 04, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 22, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 06, 2023

Major Issues Report

Form 8-K - Current report
Nov 30, 2023

Major Issues Report

Form 8-K - Current report
Nov 30, 2023

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Nov 21, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 29, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 19, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 07, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 07, 2023

Major Issues Report

Form 8-K - Current report
Jul 03, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities